Philip Y. Kouyoumdjian
PHILIP Y. KOUYOUMDJIAN is a partner in Taft’s Chicago office and a member of the firm’s Intellectual Property practice group. He litigates patent infringement cases across a range of technologies, including the pharmaceutical, mechanical and electronic arts.
Phil has litigated cases on behalf of numerous pharmaceutical companies, manufacturers of magnetics, modules, circuit protection devices and interconnect products, and makers of communications and electronics parts and devices. He has also prepared Paragraph IV Certifications and Detailed Statements in connection with numerous ANDA filings. Phil handles USPTO-related matters, including the preparation and prosecution of patent applications, appeals and re-examinations. He has drafted patent license agreements, as well as patent non-infringement and invalidity opinion letters.
In addition to patent litigation and prosecution, Phil has experience in handling complex insurance coverage matters for life and health insurers and reinsurers, as well as bad faith and punitive damages claims. He has rendered coverage advice and opinions and represented insurers in first-and third-party coverage litigation in state and federal courts. His experience in insurance coverage issues has enabled clients to share, or pass off completely, exposure to risks that presented significant liability.
Phil earned his Bachelor of Arts from Johns Hopkins University in 1989 and his J.D. from Georgetown University Law Center in 1992.
- The Medicines Company v. Apotex Inc. and Apotex Corp. Civil Action No. 3:13-cv-02891-PGS-DEA (D.N.J.) (Hatch-Waxman case involving a method of manufacturing bivalirudin – brand name: Angiomax®)
- Abbott Laboratories and Wisconsin Alumni Research Foundation v. Sandoz Inc. Civil Action No. 2:2009-cv-0215 (D.Del.) (Hatch-Waxman case involving API paricalcitol – brand name Zemplar®)
- Helsinn Healthcare S.A. and Roche Palo Alto LLC v. Sandoz Inc. Civil Action No. 11-cv-03962-MLC-TJB (D.N.J.) (Hatch-Waxman case involving API palonestron – brand name: Aloxi®)
- Dey, Inc. v. Sepracor, Inc. Civil Action No. 07-cv-2353-JGK (S.D.N.Y.) (Pharmaceutical case involving a method of administering formoterol – brand name: Brovana®)
- Eidos Display, LLC, et al. v. AU Otronics Corp. et al. Civil Action No. 6:11-cv-201-LED (E.D. Tex.) (Represented co-defendant Innolux Corp. in consumer electronics case involving method of manufacturing thin film transistors)
- Unicom Monitoring, LLC v. Cencom, Inc., et al. Civil Action No. 06-cv-01166-MLC-DEA (D.N.J.) (Represented defendant Cencom in consumer electronics case involving an alarm rerouter)
- Bel Fuse Inc., et al. v. Halo Electronics, Inc. Civil Action No. 07-cv-2168-GEB (D.N.J.) (Represented Bel Fuse in a consumer electronics case involving single- and multi-port magnetic jacks)
|News Releases | Subscribe|
|View All | Top »|